Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

[Impact of comorbidities on hemoglobin stability in patients with chronic kidney insufficiency on hemodialysis, treated with CERA in current practice: The MIRIADE study].

Frimat L, Amirou M, Jaulin JP, Sinnasse-Raymond G, Pau D, Zaoui P, Rostoker G; au nom des investigateurs participant à l’étude MIRIADE.

Nephrol Ther. 2019 Jun;15(3):162-168. doi: 10.1016/j.nephro.2018.11.006. Epub 2019 Mar 21. French.

PMID:
30905547
2.

The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward.

Rossignol P, Frimat L, Zannad F.

Kidney Int. 2019 Apr;95(4):747-749. doi: 10.1016/j.kint.2018.12.006.

PMID:
30904064
3.

Which is the best predictor of de novo donor-specific antibodies in a cohort of non-sensitized first kidney transplantation: Antigenic, allelic, epitope, or physiochemical HLA mismatches?

Delion A, Girerd S, Duarte K, Girerd N, Schikowski J, Kessler M, Frimat L, Aarnink A.

Clin Transplant. 2019 Apr;33(4):e13508. doi: 10.1111/ctr.13508. Epub 2019 Mar 22.

PMID:
30821002
4.

Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers.

Meibody F, Jamme M, Tsatsaris V, Provot F, Lambert J, Frémeaux-Bacchi V, Ducloy-Bouthors AS, Jourdain M, Delmas Y, Perez P, Darmian J, Wynckel A, Rebibou JM, Coppo P, Rafat C, Rondeau E, Frimat L, Hertig A.

Nephrol Dial Transplant. 2019 Feb 25. pii: gfz025. doi: 10.1093/ndt/gfz025. [Epub ahead of print]

PMID:
30805631
5.

Obesity phenotype and patient-reported outcomes in moderate and severe chronic kidney disease: a cross-sectional study from the CKD-REIN cohort study.

Schweitzer ML, Stengel B, Legrand K, Briançon S, Jacquelinet C, Combe C, Fouque D, Massy ZA, Laville M, Frimat L, Ayav C.

Qual Life Res. 2019 Jul;28(7):1873-1883. doi: 10.1007/s11136-019-02110-2. Epub 2019 Jan 18.

PMID:
30659448
6.

[Tubulointerstitiel nephritis and Crohn's disease, nephrotoxicity or extraintestinal manifestation of Crohn's disease? About a case].

Treffel M, Champigneulle J, Meibody F, Laurain E, Frimat L, Busby-Venner H.

Nephrol Ther. 2019 Mar;15(1):59-62. doi: 10.1016/j.nephro.2018.07.406. Epub 2018 Nov 29. French.

PMID:
30503098
7.

EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial.

Girerd S, Frimat L, Ducloux D, Le Meur Y, Mariat C, Moulin B, Mousson C, Rieu P, Dali-Youcef N, Merckle L, Lepage X, Rossignol P, Girerd N, Jaisser F.

Trials. 2018 Oct 30;19(1):595. doi: 10.1186/s13063-018-2956-1.

8.

Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014.

Girerd S, Schikowski J, Girerd N, Duarte K, Busby H, Gambier N, Ladrière M, Kessler M, Frimat L, Aarnink A.

BMC Nephrol. 2018 Sep 15;19(1):232. doi: 10.1186/s12882-018-1014-2.

9.

Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease.

Villain C, Metzger M, Combe C, Fouque D, Frimat L, Jacquelinet C, Laville M, Briançon S, Klein J, Schanstra JP, Robinson BM, Mansencal N, Stengel B, Massy ZA; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Investigators .

Nephrol Dial Transplant. 2018 Aug 28. doi: 10.1093/ndt/gfy277. [Epub ahead of print]

PMID:
30169874
10.

Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.

Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Ayav C, Speyer E, Robinson BM, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Collaborators.

Br J Clin Pharmacol. 2018 Dec;84(12):2811-2823. doi: 10.1111/bcp.13738. Epub 2018 Sep 24.

PMID:
30110711
11.

Evaluation of Subclinical Fluid Overload Using Lung Ultrasound and Estimated Plasma Volume in the Postoperative Period Following Kidney Transplantation.

Mottola C, Girerd N, Coiro S, Lamiral Z, Rossignol P, Frimat L, Girerd S.

Transplant Proc. 2018 Jun;50(5):1336-1341. doi: 10.1016/j.transproceed.2018.03.007. Epub 2018 Mar 9.

PMID:
29880355
12.

Impact of sex and glucose-lowering treatments on hypoglycaemic symptoms in people with type 2 diabetes and chronic kidney disease. The French Chronic Kidney Disease - Renal Epidemiology and Information Network (CKD-REIN) Study.

Balkau B, Metzger M, Andreelli F, Frimat L, Speyer E, Combe C, Laville M, Jacquelinet C, Briançon S, Ayav C, Massy Z, Pisoni RL, Stengel B, Fouque D.

Diabetes Metab. 2019 Apr;45(2):175-183. doi: 10.1016/j.diabet.2018.03.007. Epub 2018 Apr 6.

PMID:
29706470
13.

Risk profile, quality of life and care of patients with moderate and advanced CKD: The French CKD-REIN Cohort Study.

Stengel B, Metzger M, Combe C, Jacquelinet C, Briançon S, Ayav C, Fouque D, Laville M, Frimat L, Pascal C, Herpe YE, Morel P, Deleuze JF, Schanstra JP, Lange C, Legrand K, Speyer E, Liabeuf S, Robinson BM, Massy ZA.

Nephrol Dial Transplant. 2019 Feb 1;34(2):277-286. doi: 10.1093/ndt/gfy058.

PMID:
29635335
14.

Short Leukocyte Telomere Length Precedes Clinical Expression of Atherosclerosis: The Blood-and-Muscle Model.

Benetos A, Toupance S, Gautier S, Labat C, Kimura M, Rossi PM, Settembre N, Hubert J, Frimat L, Bertrand B, Boufi M, Flecher X, Sadoul N, Eschwege P, Kessler M, Tzanetakou IP, Doulamis IP, Konstantopoulos P, Tzani A, Korou M, Gkogkos A, Perreas K, Menenakos E, Samanidis G, Vasiloglou-Gkanis M, Kark JD, Malikov S, Verhulst S, Aviv A.

Circ Res. 2018 Feb 16;122(4):616-623. doi: 10.1161/CIRCRESAHA.117.311751. Epub 2017 Dec 14.

15.

Preemptive second kidney transplantation is associated with better graft survival compared with non-preemptive second transplantation: a multicenter French 2000-2014 cohort study.

Girerd S, Girerd N, Duarte K, Giral M, Legendre C, Mourad G, Garrigue V, Morelon E, Buron F, Kamar N, Del Bello A, Ladrière M, Kessler M, Frimat L.

Transpl Int. 2018 Apr;31(4):408-423. doi: 10.1111/tri.13105. Epub 2017 Dec 20.

16.

An Early Immediate Early Protein IE-1-Specific T-Cell Polyfunctionality Is Associated With a Better Control of Cytomegalovirus Reactivation in Kidney Transplantation.

Dekeyser M, Ladrière M, Audonnet S, Frimat L, De Carvalho Bittencourt M.

Kidney Int Rep. 2017 Mar 1;2(3):486-492. doi: 10.1016/j.ekir.2017.02.016. eCollection 2017 May. No abstract available.

17.

Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.

Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G; FRENCH Study collaborators.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1930-1940. doi: 10.2215/CJN.03030317. Epub 2017 Oct 26.

18.

Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins.

Bamoulid J, Crepin T, Gaiffe E, Laheurte C, Moulin B, Frimat L, Rieu P, Mousson C, Durrbach A, Heng AE, Rebibou JM, Saas P, Courivaud C, Ducloux D.

Transpl Immunol. 2017 Dec;45:48-52. doi: 10.1016/j.trim.2017.09.002. Epub 2017 Sep 20.

PMID:
28941751
19.

A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.

Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, Buchler M, Anglicheau D, Merville P, Lang P, Frimat L, Colosio C, Alamartine E, Kamar N, Heng AE, Durrbach A, Moal V, Rivalan J, Etienne I, Peraldi MN, Moreau A, Moulin B; French PTLD Registry.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1663-1670. doi: 10.2215/CJN.03790417. Epub 2017 Aug 17.

20.

Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey.

Rossignol P, Lamiral Z, Frimat L, Girerd N, Duarte K, Ferreira J, Chanliau J, Castin N.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2112-2118. doi: 10.1093/ndt/gfx053.

PMID:
28460113
21.

Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design.

Thilly N, Chanliau J, Frimat L, Combe C, Merville P, Chauveau P, Bataille P, Azar R, Laplaud D, Noël C, Kessler M.

BMC Nephrol. 2017 Apr 5;18(1):126. doi: 10.1186/s12882-017-0529-2.

22.

Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study.

Filipozzi P, Ayav C, Ngueyon Sime W, Laurain E, Kessler M, Brunaud L, Frimat L.

BMJ Open. 2017 Mar 27;7(3):e011482. doi: 10.1136/bmjopen-2016-011482.

23.

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study.

Peters NO, Jay N, Cridlig J, Rostoker G, Frimat L.

BMC Nephrol. 2017 Mar 20;18(1):97. doi: 10.1186/s12882-017-0513-x.

24.

[Removal and transplant, synchronised surgical procedures].

Hubert J, Frimat L.

Rev Infirm. 2016 Dec;65(226):25-27. doi: 10.1016/j.revinf.2016.09.009. French.

PMID:
27908471
25.

[First case report of Streptococcus equi subsp. zooepidemicus post-infectious acute glomerulonephritis in France].

Le-Berre N, Filipozzi P, Martin L, Frimat L, Girerd S.

Nephrol Ther. 2017 Feb;13(1):37-41. doi: 10.1016/j.nephro.2016.07.448. Epub 2016 Nov 17. French.

PMID:
27866939
26.

Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study.

Ayav C, Beuscart JB, Briançon S, Duhamel A, Frimat L, Kessler M.

BMC Nephrol. 2016 Nov 15;17(1):174.

27.

Temporal Trend and Time-Varying Effect of Preemptive Second Kidney Transplantation on Graft Survival: A 30-Year Single-Center Cohort Study.

Girerd S, Girerd N, Aarnink A, Solimando E, Ladrière M, Kennel A, Rossignol P, Kessler M, Frimat L.

Transplant Proc. 2016 Oct;48(8):2663-2668. doi: 10.1016/j.transproceed.2016.08.007.

PMID:
27788798
28.

Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults: A national retrospective strobe-compliant study.

Legendre M, Devilliers H, Perard L, Groh M, Nefti H, Dussol B, Trad S, Touré F, Abad S, Boffa JJ, Frimat L, Torner S, Seidowsky A, Massy ZA, Saadoun D, Rieu V, Schoindre Y, Heron E, Frouget T, Lionet A, Glowacki F, Arnaud L, Mousson C, Besancenot JF, Rebibou JM, Bielefeld P.

Medicine (Baltimore). 2016 Jun;95(26):e3964. doi: 10.1097/MD.0000000000003964.

29.

Anti-Donor HLA Antibody Response After Pancreatic Islet Grafting: Characteristics, Risk Factors, and Impact on Graft Function.

Pouliquen E, Baltzinger P, Lemle A, Chen CC, Parissiadis A, Borot S, Frimat L, Girerd S, Berney T, Lablanche S, Benhamou PY, Morelon E, Badet L, Dubois V, Kessler L, Thaunat O; GRAGIL Network.

Am J Transplant. 2017 Feb;17(2):462-473. doi: 10.1111/ajt.13936. Epub 2016 Jul 25.

30.

Antiplatelet and oral anticoagulant therapies in chronic hemodialysis patients: prescribing practices and bleeding risk.

Collette C, Clerc-Urmès I, Laborde-Castérot H, Frimat L, Ayav C, Peters N, Martin A, Agrinier N, Thilly N.

Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):935-43. doi: 10.1002/pds.4002. Epub 2016 May 1.

PMID:
27133538
31.

Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipients.

Bamoulid J, Courivaud C, Crepin T, Carron C, Gaiffe E, Roubiou C, Laheurte C, Moulin B, Frimat L, Rieu P, Mousson C, Durrbach A, Heng AE, Rebibou JM, Saas P, Ducloux D.

Kidney Int. 2016 May;89(5):1136-1143. doi: 10.1016/j.kint.2015.12.044. Epub 2016 Mar 2.

PMID:
27083287
32.

Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections.

Crepin T, Gaiffe E, Courivaud C, Roubiou C, Laheurte C, Moulin B, Frimat L, Rieu P, Mousson C, Durrbach A, Heng AE, Saas P, Bamoulid J, Ducloux D.

Transpl Infect Dis. 2016 Jun;18(3):415-22. doi: 10.1111/tid.12534. Epub 2016 May 21.

PMID:
27027787
33.

[The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study: To better understand chronic kidney disease].

Stengel B, Combe C, Jacquelinet C, Briançon S, Fouque D, Laville M, Frimat L, Pascal C, Herpe YÉ, Morel P, Deleuze JF, Schanstra JP, Pisoni RL, Robinson BM, Massy ZA.

Nephrol Ther. 2016 Apr;12 Suppl 1:S49-56. doi: 10.1016/j.nephro.2016.01.005. Epub 2016 Mar 11. French.

PMID:
26976057
34.

[T2HD Study. Oral anticoagulants and antiplatelet agents: Practices, benefits, and risks in the chronic hemodialysis population. Observational data].

Martin A, Thilly N, Ayav C, Clerc-Urmes I, Held P, Frimat L, Peters NO.

Nephrol Ther. 2016 Jun;12(3):156-65. doi: 10.1016/j.nephro.2015.08.005. Epub 2015 Nov 27. French.

PMID:
26631311
35.

Les cathéters cicatriciels permettent de réduire avec efficacité les douleurs pariétales postopératoires après transplantation rénale.

Alshuaibi M, Ladriere M, Eschwege P, Hubert J, Fuchs-Buder T, Frimat L, Lecoanet P.

Prog Urol. 2015 Nov;25(13):765. doi: 10.1016/j.purol.2015.08.102. French. No abstract available.

PMID:
26544297
36.

Data Mining Based On Real World Data In Chronic Kidney Disease Patients Not On Dialysis: The Key Role Of Early Hemoglobin Levels Control.

Frimat L, Pau D, Sinnasse-Raymond G, Choukroun G.

Value Health. 2015 Nov;18(7):A508. doi: 10.1016/j.jval.2015.09.1459. Epub 2015 Oct 20. No abstract available.

37.

Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis.

Brunaud L, Ngueyon Sime W, Filipozzi P, Nomine-Criqui C, Aronova A, Zarnegar R, Kessler M, Frimat L, Ayav C.

Surgery. 2016 Jan;159(1):183-91. doi: 10.1016/j.surg.2015.06.058. Epub 2015 Oct 21.

PMID:
26476826
38.

Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network.

Lablanche S, Borot S, Wojtusciszyn A, Bayle F, Tétaz R, Badet L, Thivolet C, Morelon E, Frimat L, Penfornis A, Kessler L, Brault C, Colin C, Tauveron I, Bosco D, Berney T, Benhamou PY; GRAGIL Network.

Diabetes Care. 2015 Sep;38(9):1714-22. doi: 10.2337/dc15-0094. Epub 2015 Jun 11.

PMID:
26068866
39.

ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients.

Crepin T, Carron C, Roubiou C, Gaugler B, Gaiffe E, Simula-Faivre D, Ferrand C, Tiberghien P, Chalopin JM, Moulin B, Frimat L, Rieu P, Saas P, Ducloux D, Bamoulid J.

Am J Transplant. 2015 Apr;15(4):1028-38. doi: 10.1111/ajt.13092. Epub 2015 Mar 10.

40.

[Management of idiopathic membranous nephropathy: evaluation of a standardized strategy in a Lorraine health network].

Aubertin P, Ayav C, Stolz A, Kessler M, Champigneulle J, Aymard B, Frimat L.

Nephrol Ther. 2015 Feb;11(1):16-26. doi: 10.1016/j.nephro.2014.09.004. Epub 2014 Dec 23. French.

PMID:
25547809
41.

Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.

42.

The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry.

Lassalle M, Ayav C, Frimat L, Jacquelinet C, Couchoud C; Au Nom du Registre REIN.

Nephrol Ther. 2015 Apr;11(2):78-87. doi: 10.1016/j.nephro.2014.08.002. Epub 2014 Nov 1.

PMID:
25457107
43.

Targets for parathyroid hormone in secondary hyperparathyroidism: is a "one-size-fits-all" approach appropriate? A prospective incident cohort study.

Laurain E, Ayav C, Erpelding ML, Kessler M, Briançon S, Brunaud L, Frimat L.

BMC Nephrol. 2014 Aug 13;15:132. doi: 10.1186/1471-2369-15-132.

44.

Influence on quality of life from an early cinacalcet prescription for secondary hyperparathyroidism in dialysis.

Filipozzi P, Ayav C, Erpelding ML, Kessler M, Brunaud L, Frimat L.

Pharmacoepidemiol Drug Saf. 2015 Feb;24(2):187-96. doi: 10.1002/pds.3683. Epub 2014 Aug 11.

PMID:
25111639
45.

A de novo monoclonal immunoglobulin deposition disease in a kidney transplant recipient: a case report.

Savenkoff B, Aubertin P, Ladriere M, Hulin C, Champigneulle J, Frimat L.

J Med Case Rep. 2014 Jun 18;8:205. doi: 10.1186/1752-1947-8-205.

46.

[Continuing medical education in nephrology in France: 2014 agenda].

Boffa JJ, Mercadal L, Peraldi MN, Frimat L, Moulin B.

Nephrol Ther. 2014 Jul;10(4):259-60. doi: 10.1016/j.nephro.2014.05.002. Epub 2014 Jun 6. French. No abstract available.

PMID:
24912860
47.

Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis.

Angelousi A, Girerd N, Benetos A, Frimat L, Gautier S, Weryha G, Boivin JM.

J Hypertens. 2014 Aug;32(8):1562-71; discussion 1571. doi: 10.1097/HJH.0000000000000235. Review.

PMID:
24879490
48.

Impact of anti-insulin antibodies on islet transplantation outcome: data from the GRAGIL Network.

Lablanche S, Borot S, Thaunat O, Bayle F, Badet L, Morelon E, Thivolet C, Wojtusciszyn A, Frimat L, Kessler L, Penfornis A, Brault C, Colin C, Bosco D, Berney T, Benhamou PY; GRAGIL Network.

Transplantation. 2014 Aug 27;98(4):475-82. doi: 10.1097/TP.0000000000000081.

PMID:
24837539
49.

[What's new in continuing medical education in nephrology in France?].

Moulin B, Frimat L; Avec la Commission de pédagogie et formation continue de la Société de néphrologie et les présidents de Commission.

Nephrol Ther. 2014 Apr;10(2):71-3. doi: 10.1016/j.nephro.2014.03.001. Epub 2014 Mar 21. French. No abstract available.

PMID:
24657336
50.

Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011.

Assogba FG, Couchoud C, Hannedouche T, Villar E, Frimat L, Fagot-Campagna A, Jacquelinet C, Stengel B; French Renal Epidemiology and Information Network Registry.

Diabetologia. 2014 Apr;57(4):718-28. doi: 10.1007/s00125-014-3160-9. Epub 2014 Feb 6.

PMID:
24496924

Supplemental Content

Loading ...
Support Center